Previous Article | Next Article ![]()
Journal of Virology, November 2001, p. 10800-10807, Vol. 75, No. 22
Departments of Microbiology and
Immunology1 and Biochemistry and
Molecular Pharmacology,3 Thomas Jefferson
University, Philadelphia, Pennsylvania 19107, and Institute of
Anatomy and Cell Biology, Philipps University Marburg, 65033 Marburg, Germany2
Received 15 May 2001/Accepted 6 August 2001
The pathogenicity of individual rabies virus strains appears to
correlate inversely with the extent of apoptotic cell death they induce
and with the expression of rabies virus glycoprotein, a major inducer
of an antiviral immune response. To determine whether the induction of
apoptosis by rabies virus contributes to a decreased pathogenicity by
stimulating antiviral immunity, we have analyzed these parameters in
tissue cultures and in mice infected with a recombinant rabies virus
construct that expresses the proapoptotic protein cytochrome
c. The extent of apoptosis was strongly increased in
primary neuron cultures infected with the recombinant virus carrying
the active cytochrome c gene [SPBN-Cyto c(+)], compared with cells infected with the recombinant
virus containing the inactive cytochrome c gene [SPBN-Cyto
c(
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.10800-10807.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Overexpression of Cytochrome c by a Recombinant Rabies
Virus Attenuates Pathogenicity and Enhances Antiviral
Immunity
)]. Mortality in mice infected intranasally with
SPBN-Cyto c(+) was substantially lower than in SPBN-Cyto
c(
)-infected mice. Furthermore, virus-neutralizing antibody (VNA) titers were significantly higher in mice immunized with
SPBN-Cyto c(+) at the same dose. The VNA titers induced by these recombinant viruses paralleled their protective activities against a lethal rabies virus challenge infection, with SPBN-Cyto c(+) revealing an effective dose 20 times lower than that
of SPBN-Cyto c(
). The strong increase in immunogenicity,
coupled with the marked reduction in pathogenicity, identifies the
SPBN-Cyto c(+) construct as a candidate for a live rabies
virus vaccine.
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Thomas Jefferson University, 1020 Locust St., Philadelphia, PA 19107. Phone: (215) 503-4692. Fax: (215) 923-7145. E-mail: bdietzschold{at}reddi1.uns.tju.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»